Semaglutide: drug seen as ‘game changer’ in obesity treatment



O’Rahilly, an Irish-British doctor and scientist identified for his analysis into the molecular pathogenesis of human obesity, mentioned that “this is the start of a new era for obesity drug development with the future direction being to achieve levels of weight loss comparable to semaglutide, while having fewer side effects.”



Source link Nydailynews.com

Leave a Reply

Your email address will not be published. Required fields are marked *